Dr. Hong Anna Sjolinder

Dr. Hong Anna Sjolinder is an accomplished medical professional with extensive education and degrees. She earned her MD from SICHUAN University, China, in 1989-1994. After that, she specialized in urology through a Master's training program at Tianjin Medical University, China, from 1996-1999. Then Dr. Sjolinder moved to Germany and received her PhD from the Center of Molecular Biology Heidelberg, Heidelberg University, Germany.

Dr. Sjolinder has achieved significant academic accomplishments throughout her career. She held the position of Assistant Professor at Stockholm University until 2012 when she earned the title of "Associate Professor." Dr. Sjolinder was a Regional representative to the national care program group for prostate cancer and lymphoma in 2020.

Dr. Sjölinder has held various positions in the medical field throughout her career. In 2023, she became a Senior Medical Consultant at the Department of Oncology at Linkoping University Hospital in Sweden. Prior to this, she worked as a Medical Oncologist at Malar Hospital in Eskilstuna, Sweden, from 2015-2023, and as a Urologist at Danderyd Hospital in Stockholm, Sweden, in 2014. Additionally, Dr. Sjolinder held the position of Associate Professor and a Group Leader at the Department of Molecular Biosciences at the Wenner-Gren Institute of Stockholm University from 2009-2013, and was a Clinical Researcher at the Department of Medical Biochemistry and Microbiology at Uppsala University from 2006-2008. She also worked as a Clinical Researcher at Karolinska Medical University in The Institute of Microbiology, Tumor, and Cell Biology (MTC) from 2004-2005.

Dr. Sjolinder has expertise in a variety of cancer diseases, including urological, gastrointestinal, breast, lung, and others. In particular, she is a specialist in bladder cancer, prostate cancer, renal cancer, testis cancer, colon cancer, HCC, pancreatic cancer, breast cancer, and lung cancer.